AKV is grateful to the Indian Council of Medical Research, New Delhi, India and RV to University Grants Commission, New Delhi for Research fellowships. We gratefully acknowledge the subjects who participated in this study. Electronic supplementary material Additional file 1: Real time analysis of population of (A) Methanobrevibacter in Healthy vs E. histolytica positive samples (B) Sulphur reducing bacteria in Healthy vs E. histolytica positive sample. P value = .05 or below was considered significant. Cl stands for confidence interval. (PPTX 229 KB) References 1. Rani R, Murthy RS, Bhattacharya S, Ahuja V, Rizvi MA, Paul J:

Changes in Bacterial profile during amebiasis: Demonstration of anaerobic bacteria find more in ALA pus samples. Am J Trop Med Hyg 2006, 75:880–885.PubMed

2. Jia W, Li H, Zhao L, Nicholson JK: Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 2008, 7:123–129.PubMedCrossRef 3. Whitman WB, Coleman DC, Wiebe WJ: Prokaryotes: The unseen majority. Proc Natl Acad Sci USA 1998, 95:6578–6583.PubMedCrossRef 4. Sonnenburg JL, Angenent LT, Gordon JI: Getting a grip on things: Tanespimycin cost how do communities of bacterial symbionts become established in our intestine? Nat Immunol 2004, 5:569–573.PubMedCrossRef 5. Xu J, Gordon JI: Honor thy symbionts. Proc Natl Acad Sci USA 2003, 100:10452–10459.PubMedCrossRef 6. Guarner F: Enteric flora in health and disease. Digestion 2006,73(suppl 1):5–12.PubMedCrossRef 7. O’Hara AM, Shanahan F: The gut flora as a forgotten organ. EMBO Rep 2006, 7:688–693.PubMedCrossRef 8. Ley RE, Peterson DA, Gordon JI: Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine. Cell 2006, 124:837–848.PubMedCrossRef 9. Haque R, Huston CD, Hughes M, Houpt E, Petri WA Jr: Amoebiasis. N Engl J Med 2003, 348:1565–1573.PubMedCrossRef 10. Mirelman D: selleck compound Ameba-bacterium relationship in amoebiasis. Microbiol Rev 1987, 51:272–284.PubMed 11. Mukherjee C, Clark

CG, Lohia A: Entamoeba Shows Reversible Variation in Ploidy under Different Growth Conditions and between Life Cycle Phases. PLoS Negl Trop Dis 2008, 2:e281.PubMedCrossRef 12. Simon GL, Gorbach SL: Intestinal flora in health and disease. Gastroenterology 1984, 86:174–193.PubMed 13. Leiros HKS, Kozielski-Stuhrmann S, Kapp U, Terradot L, Leonard GA, McSweeney SM: Structural Basis of 5-Nitroimidazole Antibiotic Resistance. J Biol Chem 2004, 279:55840–55849.PubMedCrossRef 14. Trinh S, Reysset G: Detection by PCR of the nim Genes Encoding 5-Nitroimidazole Resistance in Bacteroides spp. J Clin Microbiol 1996, 34:2078–2084.PubMed 15. Petri WA Jr: Amebiasis. Current treatment options in Infectious diseases 2003, 5:269–272. 16. Knight WB, Hiatt RA, Cline BL, Ritchie LS: A Modification of the Formol-Ether Concentration Technique for Increased Sensitivity in Detecting Schistosoma Mansoni Eggs. Am J Trop Med Hyg 1976, 25:818–823.PubMed 17.